Discovery of compounds that protect tyrosine hydroxylase activity through different mechanisms
Por:
Hole M, Underhaug J, Diez H, Ying M, Røhr ÅK, Jorge-Finnigan A, Fernàndez-Castillo N, Garcia-Cazorla A, Andersson KK, Teigen K and Martinez A
Publicada:
1 sep 2015
Ahead of Print:
8 may 2015
Categoría:
Analytical Chemistry
Resumen:
Pharmacological chaperones are small compounds that correct the folding
of mutant proteins, and represent a promising therapeutic strategy for
misfolding diseases. We have performed a screening of 10,000 compounds
searching for pharmacological chaperones of tyrosine hydroxylase (TH),
the tetrahydrobiopterin (BH4)-dependent enzyme that catalyzes the
rate-limiting step in the synthesis of catecholamines. A large number of
compounds bound to human TH, isoform 1 (hTH1), but only twelve
significantly protected wild-type (hTH1-wt) and mutant TH-R233H
(hTH1-p.R202H), associated to the rare neurological disorder TH
deficiency (THD), from time-dependent loss of activity. Three of them
(named compounds 2,4 and 5) were subjected to detailed characterization
of their functional and molecular effects. Whereas compounds 2 and 4 had
a characteristic pharmacological chaperone (stabilizing) effect,
compound 5 protected the activity in a higher extent than expected from
the low conformational stabilization exerted on hTH1. Compounds 4 and 5
were weak competitive inhibitors with respect to the cofactor BH4 and,
as seen by electron paramagnetic resonance, they induced small changes
to the first coordination sphere of the catalytic iron. Molecular
docking also indicated active-site location with coordination to the
iron through a pyrimidine nitrogen atom. Interestingly, compound 5
increased TH activity in cells transiently transfected with either
hTH1-wt or the THD associated mutants p.L205P, p.R202H and p.Q381K
without affecting the steady-state TH protein levels. This work revealed
different mechanisms for the action of pharmacological chaperones and
identifies a subtype of compounds that preserve TH activity by weak
binding to the catalytic iron. This article is part of a Special Issue
entitled: Cofactor-dependent proteins: Evolution, chemical diversity and
bio-applications. (C) 2015 Elsevier B.V. All rights reserved.
|